Search research articles
Contact Us
Filters
Showing results (631-640 of 638) with videos related to
Page
of 64
Sort By:
You have reached the last page of results.
This site can display upto 638 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50
J F Gainor, H Rizvi, E Jimenez Aguilar, et al.
Human Gene Therapy
|
August 20, 1996
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy
|
December 28, 1999
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy
|
December 1, 1996
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy
|
February 4, 1998
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Cancer Gene Therapy
|
May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)
N Yen, C G Ioannides, K Xu, et al.
Journal of the National Cancer Institute
|
May 18, 1999
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
S G Swisher, J A Roth, J Nemunaitis, et al.
Human Gene Therapy
|
April 25, 2000
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Page
of 64
Search research articles
Search
Showing results (631-640 of 638) with videos related to
Sort By:
Page
of 64
You have reached the last page of results.
This site can display upto 638 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50
J F Gainor, H Rizvi, E Jimenez Aguilar, et al.
Human Gene Therapy
|
August 20, 1996
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy
|
December 28, 1999
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy
|
December 1, 1996
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy
|
February 4, 1998
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Cancer Gene Therapy
|
May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)
N Yen, C G Ioannides, K Xu, et al.
Journal of the National Cancer Institute
|
May 18, 1999
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
S G Swisher, J A Roth, J Nemunaitis, et al.
Human Gene Therapy
|
April 25, 2000
Human gene marker/therapy clinical protocols
S A Rosenberg, R M Blaese, M K Brenner, et al.
Page
of 64